Term
3 components of the JG apparatus |
|
Definition
1)Macula Densa 2)Juxtaglomerular cells 3)Mesangial cells |
|
|
Term
|
Definition
|
|
Term
where are JG cells located? |
|
Definition
Mostly in the afferent arteriole but some in efferent |
|
|
Term
The macula densa responds to changes in _______ concentration in the distal convoluted tubule. |
|
Definition
|
|
Term
Low Na in the DCT causes the release of what 3 mediators? |
|
Definition
1)adenosine 2)Prostaglandin 3)NO |
|
|
Term
When macula densa cells swell NO is produced leading to the upregulation of ________ which synthesizes prostaglandins from arachidonic acid. |
|
Definition
|
|
Term
What are the three pathways that contribute to renin release from the JG cells during hypotension? |
|
Definition
1)intrarenal artery baroreceptors 2)carotid sinus baroreceptors through B1 3)Macula densa release of mediators |
|
|
Term
Angiotensinogen is converted to Angiotensin I by ______________ |
|
Definition
|
|
Term
Angiotensin I is converted to Angiotensin II by ____________ |
|
Definition
ACE (angiotensin converting enzyme) |
|
|
Term
5 effects of angiotensin II |
|
Definition
1)increase in sympathetic activity leading to vasoconstriction 2)Tubular Na & Cl reabsorption and K excretion 3)release of aldosterone from the adrenal gland (also, increases absorption of Na & Cl and release of K) 4)arteriolar vasoconstriction causing increased blood pressure 5)ADH secretion by pituitary gland (acts on collecting duct for H2O absorption) |
|
|
Term
What are some negative long term effects of angiotensin II? |
|
Definition
vascular and cardiac hypertrophy and remodeling |
|
|
Term
If you block ACE you will increase __________ |
|
Definition
Bradykinin which is a potent vasodilator (bradykinin is usually broken down by ACE) |
|
|
Term
3 areas that may be targeted by drugs to counteract effects of angiotensin? |
|
Definition
1)renin site 2)ACE itself 3)receptors for Angiotensin II (which would circumvent the secondary effect of increasing bradykinin when targeting ACE itself) |
|
|
Term
only renin inhibitor we discussed? |
|
Definition
|
|
Term
Aliskiren is used to treat _________ |
|
Definition
|
|
Term
3 side effects of aliskiren |
|
Definition
1)hyperkalemia 2)renal impairment 3)teratogen |
|
|
Term
|
Definition
1)Captopril 2)Enalopril 3)Fosinopril 4)Lisinopril |
|
|
Term
____________ is the only ACE inhibitor which may be given parenterally. |
|
Definition
|
|
Term
Indications for ACE inhibitor use (7) |
|
Definition
1)Hypertension 2)congestive heart failure 3)acute MI (diabetic and hypertensive pts) 4)pts with cardiovascular risk(thrombotic disorders) b/c ACE helps maintain higher level of plasminogen 5)chronic renal failure (diabetes/diabetic nephropathy) 6)prevent glomerulosclerosis in diabetes even in absence of hyoertension 7)Scleroderma renal crisis |
|
|
Term
In the case of secondary HTN associated with fibromuscular dysplasia or atherosclerosis of the renal arteries do not use __________ to treat hypertension |
|
Definition
ACE inhibitors; b/c the sclerotic renal arteries caused drop in GFR that caused renin-angiotensin syst activation. Angiotensin II caused constriction in the efferent vessels to increase GFR and overcome lack of hydrostatic pressure in afferent due to the sclerotic artery. Use of ACE will cause GFR to drop and kidneys to fail. |
|
|
Term
Most common side effect of ACE inhibitors is _________ |
|
Definition
dry cough likely from increased bradykinin (this would be circumvented if receptors of ACE were targeted rather than ACE itself |
|
|
Term
Angioedema and cough distinguish ACE inhibitors from __________ |
|
Definition
|
|
Term
Toxicity of ACE inhibitors (9, simple list) |
|
Definition
1)Hypotension 2)cough 3)Hyperkalemia 4)Acute renal failure 5)teratogenic 6)skin rash 7)proteinuria 8)angioedema 9)dysgeusia (change in sense of taste) |
|
|
Term
5 main Angiotensin II receptor blockers |
|
Definition
1)Irbesartan 2)Losartan 3)Olmesartan 4)Telmisartan 5)Valsartan |
|
|
Term
Toxicity of angiotensin II receptor blockers (3) |
|
Definition
1)Hyperkalemia 2)acute renal failure 3)teratogenic |
|
|